Purchase Order W81K0017P0486
Award Date
7/15/17
Potential Completion Date
9/30/18
Potential Value
$231K
Federal Agency
Medical Command
Awardee
Quva Pharma, Inc.
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
Total Small Business
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Sugar Land, TX 77478, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
2
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price purchase order awarded by the U.S. Army Medical Command (MEDCOM) to Quva Pharma, Inc., a small business contractor. The contract, valued at $95,227.80, is for the delivery of compounded pharmaceutical products to the Carl R. Darnall Army Medical Center at Fort Hood, Texas. The contract was set aside for small business contractors and has an ultimate completion date of September 30, 2019. Quva Pharma is a 503B outsourcing facility that specializes in providing sterile...
This is a firm fixed price delivery order awarded by the Department of Health and Human Services' National Institutes of Health Clinical Center to Quva Pharma, Inc., a 503B outsourcing facility that provides sterile compounded pharmaceutical products to federal agencies. The contract is for outsourcing patient-controlled analgesia systems (PCACs) and epidurals, with a potential value of $250,000.00 and a completion date of September 30, 2024. Quva Pharma has previously held prime federal...
This federal contract was awarded by the National Institutes of Health (NIH) Clinical Center, a civilian federal agency, to Quva Pharma, Inc. on February 19, 2025. The $100,000.00 firm fixed-price purchase order is for the delivery of specialized pharmaceutical products, including sterile intravenous medications, patient-controlled analgesia systems, and epidural products, to support the NIH Clinical Center's pain management initiatives and clinical research needs. Quva Pharma, Inc. is a...
Quva Pharma, Inc. was awarded a $100,000 firm fixed price delivery order against an unspecified multiple award contract vehicle by the Department of Health and Human Services' National Institutes of Health Clinical Center. The delivery order, numbered 1327585 under request for proposal number 20-001401, is for unspecified products or services to be provided by Quva Pharma, Inc. as the prime contractor. Performance will occur in Sugar Land, Texas, with an anticipated completion date of October...
This federal contract award from the Defense Logistics Agency (DLA) is for the delivery of Quviviq 50 mg tablet 30s, a pharmaceutical product, to the government. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, and has a ceiling value of $1,081.73. The contract type is a Delivery Order with a Firm Fixed Price pricing structure, and the ultimate completion date is December 28, 2023. The contract award is not...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of QUVIVIQ 25 MG TABLET 30S, a pharmaceutical product, with a ceiling value of $1,528.80 and a completion date of February 4, 2025. This contract is not designated as a set-aside and is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds...
This federal contract award is for the delivery of the pharmaceutical product QUVIVIQ 50 MG TABLET 30S to the U.S. Defense Logistics Agency (DLA) Troop Support Medical. The $1,112.65 firm fixed price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on September 10, 2024, with an ultimate completion date of September 11, 2024. This award is a child contract under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. government. The $1,809.92 Firm Fixed Price Delivery Order is for the provision of the drug QUVIVIQ 25 MG TABLET 30S. The contract has an ultimate completion date of June 10, 2024. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
This is a $3,214.15 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of MENQUADFI VIAL 0.5ML, a medical product, with a period of performance through December 23, 2024. The award is associated with a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at $999,999,999 and...
This federal contract award, valued at $4,160.03, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of medical supplies, including the pharmaceutical product QUVIVIQ 25 MG TABLET 30S. This is a delivery order contract with a firm fixed price pricing type, and does not have a set-aside designation. The contract is associated with a larger Indefinite Delivery Contract (IDC) that...